Suchergebnisse - (Person:"Pierson, Sheila K")

PubPharm (5)

1

Siltuximab administration results in spurious IL-6 elevation in peripheral blood

enthalten in: American journal of hematology | 2024

von Mango, N. | Pierson, S. | Sarmiento Bustamante, M. | +3

2

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

enthalten in: Blood advances | 2023

von Pierson, S. | Lim, M. | Srkalovic, G. | +13

3

Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease : secondary analyses of phase II clinical trial data

enthalten in: British journal of haematology | 2019

von Morra, D. | Pierson, S. | Shilling, D. | +6

4

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

5

Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2018

von Pierson, S. | Stonestrom, A. | Shilling, D. | +8

1
[1]